Clinical Trial Update: Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing thrice-daily premixed human insulin with basal-bolus insulin therapy in patients with poorly controlled Type 2 diabetes; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal-bolus insulin therapy
• Premixed human insulin (thrice-daily) (insulin human premixed)

Snippet

Sponsor: Hospital Sultanah Aminah Johor Bahru | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED